193 related articles for article (PubMed ID: 21477078)
1. Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition.
Cohen-Solal KA; Merrigan KT; Chan JL; Goydos JS; Chen W; Foran DJ; Liu F; Lasfar A; Reiss M
Pigment Cell Melanoma Res; 2011 Jun; 24(3):512-24. PubMed ID: 21477078
[TBL] [Abstract][Full Text] [Related]
2. Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma.
Abushahba W; Olabisi OO; Jeong BS; Boregowda RK; Wen Y; Liu F; Goydos JS; Lasfar A; Cohen-Solal KA
PLoS One; 2012; 7(10):e47312. PubMed ID: 23077590
[TBL] [Abstract][Full Text] [Related]
3. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-{beta}-inducible phosphorylation of Smad3.
Wang G; Matsuura I; He D; Liu F
J Biol Chem; 2009 Apr; 284(15):9663-73. PubMed ID: 19218245
[TBL] [Abstract][Full Text] [Related]
6. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines.
Rich JN; Zhang M; Datto MB; Bigner DD; Wang XF
J Biol Chem; 1999 Dec; 274(49):35053-8. PubMed ID: 10574984
[TBL] [Abstract][Full Text] [Related]
8. Involvement of deterioration in S100C/A11-mediated pathway in resistance of human squamous cancer cell lines to TGFbeta-induced growth suppression.
Sonegawa H; Nukui T; Li DW; Takaishi M; Sakaguchi M; Huh NH
J Mol Med (Berl); 2007 Jul; 85(7):753-62. PubMed ID: 17476473
[TBL] [Abstract][Full Text] [Related]
9. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells.
Zelivianski S; Cooley A; Kall R; Jeruss JS
Mol Cancer Res; 2010 Oct; 8(10):1375-87. PubMed ID: 20736297
[TBL] [Abstract][Full Text] [Related]
11. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
12. The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling.
Liang J; Zhou Y; Zhang N; Wang D; Cheng X; Li K; Huang R; Lu Y; Wang H; Han D; Wu W; Han M; Miao S; Wang L; Zhao H; Song W
J Biol Chem; 2021; 296():100512. PubMed ID: 33676893
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2.
Giannouli CC; Kletsas D
Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081
[TBL] [Abstract][Full Text] [Related]
14. Flavopiridol Inhibits TGF-
Rostam MA; Shajimoon A; Kamato D; Mitra P; Piva TJ; Getachew R; Cao Y; Zheng W; Osman N; Little PJ
J Pharmacol Exp Ther; 2018 Apr; 365(1):156-164. PubMed ID: 29438988
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
[TBL] [Abstract][Full Text] [Related]
16. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
[TBL] [Abstract][Full Text] [Related]
17. Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?
Lasfar A; Cohen-Solal KA
Carcinogenesis; 2010 Oct; 31(10):1710-7. PubMed ID: 20656791
[TBL] [Abstract][Full Text] [Related]
18. Interaction of ERK1/2 and Smad2/3 signaling pathways in TGF-β1-induced TIMP-3 expression in rat chondrocytes.
Wang X; Zhu Y; Tao H; Jin C; Liu Y; Lu X; Hu X; Fan C
Arch Biochem Biophys; 2014 Dec; 564():229-36. PubMed ID: 25245272
[TBL] [Abstract][Full Text] [Related]
19. Osteoarthritis-Related Inflammation Blocks TGF-β's Protective Effect on Chondrocyte Hypertrophy via (de)Phosphorylation of the SMAD2/3 Linker Region.
Thielen N; Neefjes M; Wiegertjes R; van den Akker G; Vitters E; van Beuningen H; Blaney Davidson E; Koenders M; van Lent P; van de Loo F; van Caam A; van der Kraan P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360888
[TBL] [Abstract][Full Text] [Related]
20. TGFβ-induced early activation of the small GTPase RhoA is Smad2/3-independent and involves Src and the guanine nucleotide exchange factor Vav2.
Papadimitriou E; Kardassis D; Moustakas A; Stournaras C
Cell Physiol Biochem; 2011; 28(2):229-38. PubMed ID: 21865730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
